2021
DOI: 10.1016/j.jid.2020.12.034
|View full text |Cite
|
Sign up to set email alerts
|

CCR4 Involvement in the Expansion of T Helper Type 17 Cells in a Mouse Model of Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 40 publications
3
11
0
Order By: Relevance
“…Besides CCR10, other chemokine receptors such as CCR6 and CCR4 are also expressed on skin-homing or resident T cells to regulate their localization and function under homeostatic and inflammatory conditions ( Andrew et al., 2001 ; Baekkevold et al., 2005 ; Cai et al., 2011 ; Gray et al., 2011 ; Jiang et al., 2010 ) ( Campbell et al., 2007 ; Casciano et al., 2020 ; Matsuo et al., 2021 ; Puig et al., 2022 ). These chemokine receptors could have redundant functions in directing localization of CCR10 + T cells into the skin in absence of CCL27.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Besides CCR10, other chemokine receptors such as CCR6 and CCR4 are also expressed on skin-homing or resident T cells to regulate their localization and function under homeostatic and inflammatory conditions ( Andrew et al., 2001 ; Baekkevold et al., 2005 ; Cai et al., 2011 ; Gray et al., 2011 ; Jiang et al., 2010 ) ( Campbell et al., 2007 ; Casciano et al., 2020 ; Matsuo et al., 2021 ; Puig et al., 2022 ). These chemokine receptors could have redundant functions in directing localization of CCR10 + T cells into the skin in absence of CCL27.…”
Section: Discussionmentioning
confidence: 99%
“…Mice deficient of CCR6 or its ligand CCL20 have reduced skin inflammation in response to the IMQ stimulation ( Campbell et al., 2017 ; Cochez et al., 2017 ; Robert et al., 2017 ; Shi et al., 2021 ; Yu et al., 2019 ), suggesting that in contrast to the CCR10/CCL27 axis, the CCR6/CCL20 axis promotes the skin γδT17 cell activation and tissue inflammation. CCR4 is preferentially expressed in skin Th17 but not γδT17 cells and CCR4-deficient mice also have reduced skin inflammation in response to topical IMQ stimulation ( Matsuo et al., 2021 ). Corroborating with these mouse studies, clinical observations found that expression of CCL17, the ligand of CCR4, and CCL20 is increased, whereas CCL27 is decreased in the lesional skin of psoriatic patients ( Gudjonsson et al., 2010 ; Homey et al., 2000a ; Kim et al., 2014 ; Quaranta et al., 2014 ; Sahmatova et al., 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Previously, we have shown that DCs in regional lymph nodes produce CCL22 and attract CCR4-expressing Th17 to enhance DC-Th17 interactions [ 46 , 85 ]. This promotes the expansion of Th17 cells and subsequent induction of CTLs in murine melanoma and psoriasis models [ 13 , 14 ]. Thus, in certain types of cancer, CCR4 may play a role in anti-tumor immunity not only by recruiting Th17 cells into tumor tissues but also by promoting Th17 cell expansion in the draining lymph nodes with subsequent Th17-mediated CTL induction.…”
Section: Th17 Cellmentioning
confidence: 99%
“…While initial studies have suggested protumor activities of Th17 cells, recent studies have demonstrated an important role of Th17 in the induction of CTLs [ 140 , 141 , 142 , 143 ]. Our previous studies have further shown that CCR4 plays an essential role in Th17 expansion and subsequent CTL induction by promoting DC-Th17 interactions in the regional lymph nodes [ 13 , 14 ]. Thus, CCR4 may also substantially contribute to anti-tumor immunity through the expansion of Th17 cells and subsequent induction of tumor-specific CTLs in certain types of cancer.…”
Section: The Chemokine Superfamily As Therapeutic Targets In Cancer Immunotherapymentioning
confidence: 99%
See 1 more Smart Citation